Recombinant viruses, preparation and use in genic therapy

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/86 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 38/18 (2006.01) A61K 48/00 (2006.01) C07K 14/475 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/18 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2184200

Recombinant adenoviruses comprising a heterologous DNA sequence coding for brain-derived neurotrophic factor (BDNF), preparation thereof, and use thereof for treating and/or preventing degenerative neurological diseases.

La présente invention concerne des adénovirus recombinants comportant une séquence d'ADN hétérologue codant pour le facteur neurotrophique dérivé du cerveau (BDNF), leur préparation, et leur utilisation pour le traitement et/ou la prévention des maladies neurodégénératives.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant viruses, preparation and use in genic therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant viruses, preparation and use in genic therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant viruses, preparation and use in genic therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2068548

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.